
BIOIMPACT CAPITAL LLC
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | CNTX | 10.68M | $27.98M |
![]() | CGEM | 7.65M | $108.68M |
![]() | DBVT | 5.21M | $108.91M |
![]() | AKTS | 4.84M | $86.51M |
![]() | TRVI | 3.30M | $39.35M |
![]() | ALMS | 2.39M | $52.58M |
![]() | RLAY | 2.36M | $23.48M |
![]() | ALLO | 2.24M | $5.47M |
![]() | ENGN | 1.85M | $12.57M |
![]() | MLTX | 1.81M | $33.76M |
![]() | ORIC | 1.80M | $22.86M |
![]() | CRVS | 1.67M | $24.50M |
![]() | EWTX | 1.66M | $52.31M |
![]() | EVMN | 1.46M | $33.47M |
![]() | DYN | 1.41M | $25.53M |
![]() | LQDA | 1.41M | $53.03M |
![]() | QURE | 1.37M | $22.39M |
![]() | SNDX | 1.34M | $31.32M |
![]() | AGIO | 1.31M | $44.19M |
![]() | HOWL | 1.21M | $1.01M |

Context Therapeutics Inc.
CNTX
Shares Held
10.68M
Value
$27.98M

Cullinan Therapeutics, Inc.
CGEM
Shares Held
7.65M
Value
$108.68M

DBV Technologies S.A.
DBVT
Shares Held
5.21M
Value
$108.91M

Aktis Oncology, Inc.
AKTS
Shares Held
4.84M
Value
$86.51M

Trevi Therapeutics, Inc.
TRVI
Shares Held
3.30M
Value
$39.35M

Alumis Inc. Common Stock
ALMS
Shares Held
2.39M
Value
$52.58M

Relay Therapeutics, Inc.
RLAY
Shares Held
2.36M
Value
$23.48M

Allogene Therapeutics, Inc.
ALLO
Shares Held
2.24M
Value
$5.47M

enGene Holdings Inc.
ENGN
Shares Held
1.85M
Value
$12.57M

MoonLake Immunotherapeutics
MLTX
Shares Held
1.81M
Value
$33.76M

ORIC Pharmaceuticals, Inc.
ORIC
Shares Held
1.80M
Value
$22.86M

Corvus Pharmaceuticals, Inc.
CRVS
Shares Held
1.67M
Value
$24.50M

Edgewise Therapeutics, Inc.
EWTX
Shares Held
1.66M
Value
$52.31M

Evommune, Inc.
EVMN
Shares Held
1.46M
Value
$33.47M

Dyne Therapeutics, Inc.
DYN
Shares Held
1.41M
Value
$25.53M

Liquidia Corporation
LQDA
Shares Held
1.41M
Value
$53.03M

uniQure N.V.
QURE
Shares Held
1.37M
Value
$22.39M

Syndax Pharmaceuticals, Inc.
SNDX
Shares Held
1.34M
Value
$31.32M

Agios Pharmaceuticals, Inc.
AGIO
Shares Held
1.31M
Value
$44.19M

Werewolf Therapeutics, Inc.
HOWL
Shares Held
1.21M
Value
$1.01M
